ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 227 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $887,684,000 | 7.26% |
| Avoro Capital Advisors LLC | 1,630,000 | $56,039,000 | 7.16% |
| ACUTA CAPITAL PARTNERS, LLC | 572,756 | $19,691,000 | 4.67% |
| HWG Holdings LP | 100,994 | $3,472,000 | 4.38% |
| HARVEY CAPITAL MANAGEMENT INC | 230,350 | $7,919,000 | 3.56% |
| SECTORAL ASSET MANAGEMENT INC | 671,113 | $23,073,000 | 2.70% |
| Palo Alto Investors LP | 1,590,430 | $54,679,000 | 2.58% |
| Ghost Tree Capital, LLC | 350,000 | $12,033,000 | 2.24% |
| GARRISON BRADFORD & ASSOCIATES INC | 72,550 | $2,494,000 | 2.20% |
| EMORY UNIVERSITY | 56,135 | $1,930,000 | 1.82% |